SOPHiA GENETICS SA (SOPH), a cloud-native healthcare technology, on Friday said it closed a $57 million public offering of shares announced on June 16.
The offering was oversubscribed, and the underwriters exercised in full their option to purchase an additional 1,578,900 ordinary shares at the offering price.
The company sold a total of 12,104,900 ordinary shares at an offering price of $4.75 per share.
TD Cowen acted as the lead book-running manager for the offering. Guggenheim Securities acted as book-running manager, while BTIG and Craig-Hallum acted as lead managers for the offering.
SOPH closed Thursday's trade at $5.46, up 4.20%. In the overnight market, shares are trading at $5.44, down 0.37%.
For more such biotech stock news, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.